Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01719497 · ClinicalTrials.gov registry record
Imaging of Cannabinoid 1 Receptors Using [11C]OMAR and PET
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 74
- Enrollment target
NCT01719497: Completed study, sponsored by Yale University.
NCT01719497 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 74 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01719497 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
Study Summary
The aim of the present study is to conduct a human trial of \[C-11\]OMAR, a new PET imaging agent for the brain cannabinoid type 1 receptors (CB1), to determine its pharmacokinetics and binding characteristics.
Interventions
- DRUG [C-11]OMAR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2009-06 |
| Est. Completion | 2014-05 |
What the finished NCT01719497 record still lists
NCT01719497 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 74 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which [C-11]OMAR is the first listed.
NCT01719497 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01719497 about?
NCT01719497 is a clinical study titled "Imaging of Cannabinoid 1 Receptors Using [11C]OMAR and PET". The aim of the present study is to conduct a human trial of \[C-11\]OMAR, a new PET imaging agent for the brain cannabinoid type 1 receptors (CB1), to determine its pharmacokinetics and binding characteristics.
What is the current status of trial NCT01719497?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2009-06. Estimated completion is 2014-05.
What interventions are being tested in trial NCT01719497?
The interventions under investigation include: [C-11]OMAR (DRUG).
Who is sponsoring clinical trial NCT01719497?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia